Get the Stockscreener App
4.255
0.00%
0.00
Clover Health Investments Corp stock is traded at $4.255, with a volume of 2.06M.
It is up +0.00% in the last 24 hours and down -0.35% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$4.255
Open:
$4.23
24h Volume:
2.06M
Relative Volume:
0.31
Market Cap:
$2.26B
Revenue:
$2.21B
Net Income/Loss:
$-56.94M
P/E Ratio:
-37.86
EPS:
-0.1124
Net Cash Flow:
$54.54M
1W Performance:
+0.59%
1M Performance:
-0.35%
6M Performance:
+96.99%
1Y Performance:
+58.18%
1-Day Range:
$4.22
$4.285
1-Week Range:
$4.14
$4.3695
52-Week Range:
$1.58
$5.59
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.255 | 2.18B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
397.14 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
96.74 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
407.50 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
282.52 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
401.54 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health (CLOV) Q2 2026 Earnings Call Transcript - AOL.com
Clover Health Highlights CA Cohort Maturation Growth and 4.5-Star 2027 Impact - Minichart
Clover Health Highlights Depth-Focused Strategy and Technology Investments - TipRanks
Clover Health Investments : 2Q26 Supplemental Q&A - marketscreener.com
Clover publishes Q2 2026 supplemental Q&A highlighting Clover Assistant impact and strategy - TradingView
Health Insurance Providers Stocks Q2 Teardown: Clover Health (NASDAQ:CLOV) Vs The Rest - Barchart.com
Are These Penny Stocks Worth Watching? MSB, CLOV and HYLN - Kalkine Media
Clover Health's High Valuation Ignores Low-Margin Structural Realities (NASDAQ:CLOV) - Seeking Alpha
Q2 2026 Clover Health Investments Corp Earnings Call Transcript - GuruFocus
Q1 2026 Clover Health Investments Corp Earnings Call Transcript - GuruFocus
Clover Health interim CFO Thornton sells $78,032 in shares By Investing.com - Investing.com South Africa
Clover Health interim CFO Thornton sells $78,032 in shares - Investing.com
Clover Health (NASDAQ: CLOV) CFO’s tax sale covers RSU vesting - Stock Titan
Clover Health (NASDAQ: CLOV) notes $21K 10b5-1 sale by Thornton - Stock Titan
Clover Health Investments (NASDAQ:CLOV) Trading Down 5.7%Time to Sell? - MarketBeat
Clover Health (CLOV) Rises 2.45% to $4.60 as Momentum Builds Toward ResistanceSmart Beta Flow - Vinanet
Clover Health Investments (NASDAQ:CLOV) Cut to Buy at Wall Street Zen - MarketBeat
Clover Health Investments, Corp. • Robinhood Token Price, CLOV Price, Live Charts, and Marketcap - Coinbase
Clover Health Investments: Real Turnaround, But Already Priced In (NASDAQ:CLOV) - Seeking Alpha
Shareholder in CLOV (CLOV) registers 474,801 shares for potential sale - Stock Titan
Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run? - Yahoo Finance
Clover Health Is Proving Its Profit Model (NASDAQ:CLOV) - Seeking Alpha
Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV? - Yahoo Finance
The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call - Yahoo Finance
Clover Health Investments, Corp. • Robinhood Token (CLOV) Price Prediction for 2026 to 2031 - Bybit
Clover Health Investments, Corp. (CLOV) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
About Clover Health Investments, Corp. • Robinhood Token - Coinbase
Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting - Kalkine Media
Clover Health (CLOV) Slips 1.54% to $4.47 as Support at $4.25 Comes into FocusMomentum ETF - Vinanet
Clover Health Investments, Corp. • Robinhood Token (CLOV) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
Clover Health (CLOV) Climbs 3.4% to $4.54 as Attention Turns to $4.77 ResistanceNew Highs New Lows - Vinanet
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth - MarketBeat
Clover Health Investments (NASDAQ:CLOV) Shares Down 4.7% After Insider Selling - MarketBeat
Clover Health at Canaccord Genuity conference: growth meets profit - Investing.com
Clover Health CEO Andrew Toy sells $408,260 in stock By Investing.com - Investing.com Canada
Clover Health CEO Andrew Toy sells $408,260 in stock - Investing.com
Clover Health Investments (NASDAQ:CLOV) CEO Andrew Toy Sells 87,798 Shares - MarketBeat
Clover Health (CLOV) CEO Andrew Toy sells 87,798 shares for tax withholding - Stock Titan
CLOV (Nasdaq: CLOV) discloses planned 85,704-share sale by Andrew Toy - Stock Titan
Clover Health releases transcript of Q2 2026 earnings call - Bitget
Clover Health Investments : 2Q26 Earnings Call Transcript - marketscreener.com
Clover Health Earnings Call Signals Profitable Growth - TipRanks
Clover Health (CLOV) Is Up 14.1% After Raising 2026 Profit Outlook And Returning To Net Income - simplywall.st
Clover Health Investments (NASDAQ:CLOV) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat
CLOV SWOT Analysis: Financial Resilience and Growth Potential Re - GuruFocus
Clover Health (NASDAQ: CLOV) holder files Form 144 for major stock sales - Stock Titan
Clover stock seeks strong conclusion to week - Nashville Post
Clover Health Investments, Corp. 2Q 2026: Revenue $743.2M, EPS $0.05— 10-Q Summary - TradingView
3 Growth Companies With Insider Ownership Up To 21% - simplywall.st
CLOV Maintained by UBS -- Price Target Raised to $5.00 - GuruFocus
Clover Health Investments (NASDAQ:CLOV) Shares Gap UpHere's Why - MarketBeat
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clover Health Investments Corp Stock (CLOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| THORNTON JOSEPH CLAY | Interim CFO |
Aug 17 '26 |
Sale |
4.39 |
17,775 |
78,032 |
1,249,526 |
0.04%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):